Boston Scientific wins CE mark for 25-mm drug-eluting Lotus Transcatheter Aortic Valve

Boston Scientific's ($BSX) Ranger drug-coated balloon catheter was recently awarded a CE mark for its 25-mm Lotus Transcatheter Aortic Valve Implantation System, giving the company a new presence in the endovascular market complementing its 23-mm and 27-mm versions. The product, used to treat peripheral artery disease, will optimize drug delivery while using Sterling balloon technology and a paclitaxel coating to treat diseased vascular tissue without leaving a permanent implant. Currently, the product is being launched in Europe. Story

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.